Retatrutide 5mg + Cagrilintide 5mg

10mg · Lyophilized Powder

This research blend pairs Retatrutide, a triple agonist of the GLP-1, GIP, and glucagon receptors, with Cagrilintide, a long-acting amylin analogue, in a single 10mg vial (5mg + 5mg). The combination is studied for complementary effects on energy balance, appetite signalling, and glucose metabolism, with the amylin pathway theorised to enhance satiety while incretin and glucagon agonism drive energy expenditure and lipolysis. Preclinical and early clinical research explores whether co-administration produces additive metabolic and weight-management effects beyond either compound alone.

All products sold by JA Performance Peptides are intended strictly for laboratory research purposes and are not approved for human consumption, veterinary use, or therapeutic application. Not for human use.